Benefits
Company-reported observational study in 167 women (unpublished)
The maker, Nexira, says it ran an observational study in 167 women and reported improvements in menstrual discomfort, mood and energy, and quality of life. That study has not been published in a peer-reviewed journal, so the dose, the design, the size of any change and the statistics cannot be checked by anyone outside the company. It also had no placebo group and no comparison group. PMS symptoms swing a lot from cycle to cycle and respond strongly to placebo, so improvements collected this way cannot be credited to the product, and an uncontrolled report also cannot establish tolerability at a dose the company has not disclosed.
Marketed for both phases, but only one has been tested
The product is marketed as covering both the run-up to a period and the period itself, but the published evidence does not cover both. The one placebo-controlled yarrow trial cited here enrolled young women with primary dysmenorrhea and measured period pain only; it did not measure mood, bloating or other premenstrual symptoms in the days before bleeding. The magnesium papers cited are review articles about ordinary magnesium, not tests of this product. Treat the two-phase claim as marketing positioning rather than a tested result.
Magnesium and PMS: what the two cited reviews say
The two magnesium papers cited on this page are review articles, not new trials, and both cover ordinary magnesium rather than the marine magnesium in this product. A 2017 review in Magnesium Research concluded that magnesium supplementation may help with period pain and premenstrual symptoms. A 2017 systematic review in Nutrients found that four of seven PMS studies reported a benefit of magnesium for anxiety, which also means three did not. Reviews pool older studies of varying quality, none of them tested BloomEase, and there is no published comparison of marine magnesium against cheaper magnesium forms.
Yarrow: one placebo-controlled trial in women with painful periods
Yarrow (Achillea millefolium) has a long history of traditional use for menstrual discomfort in European herbal medicine. There is also one modern human trial: a 2015 double-blind randomized study in the Journal of Pediatric and Adolescent Gynecology, done in young women with primary dysmenorrhea (period pain with no underlying medical cause), which reported lower pain scores with yarrow than with placebo after one and two months. That trial tested yarrow on its own, not the yarrow plus marine magnesium combination sold as BloomEase, and a single study needs independent replication before it is settled. Yarrow's proposed active compounds, including chamazulene, apigenin, luteolin and sesquiterpene lactones, relax smooth muscle in laboratory and animal experiments, which is a plausible explanation rather than proof in people. Period pain that is severe, new or getting worse should be assessed by a doctor rather than self-treated.
Mechanism of action
Magnesium muscle relaxation and neuromuscular signaling
Magnesium is a cofactor in over 300 enzymatic reactions and is a natural calcium antagonist at smooth muscle. In theory, adequate magnesium status could help uterine muscle relax, which is the proposed reason magnesium might ease cramps. This is a mechanism, not something the cited papers measured in people taking this product.
Magnesium and mood regulation
Magnesium plays a role in serotonergic signaling, NMDA receptor modulation, and HPA axis regulation. Low magnesium levels have been linked with mood symptoms in observational data, which shows an association rather than cause and effect. In the systematic review cited here, four of seven PMS studies reported a benefit for anxiety and three did not, so the human evidence is mixed and any effect appears small.
Yarrow antispasmodic compounds
Apigenin, luteolin and sesquiterpene lactones from yarrow relax smooth muscle in laboratory and animal studies. That is the proposed explanation for the traditional use for cramps, but test-tube and animal results do not by themselves show what happens in people.
Clinical trials
Real-life observational study in 167 women across menstrual cycles, reporting benefits on three pillars: menstrual discomfort, mood and energy, and quality of life.
167 women
This is not a published study. Nexira reports that 167 women were followed across menstrual cycles and that menstrual discomfort, mood and energy, and quality of life improved. There was no placebo group and no comparison group, everyone knew what they were taking, and the dose, the main outcome measure and the statistical analysis have never been released, so nothing here can be checked independently. PMS symptoms vary naturally from cycle to cycle and respond strongly to placebo, so improvements recorded this way cannot be attributed to the product. Treat it as a company report rather than evidence.
Placebo-controlled trial reported magnesium 200 mg/day modestly reduced PMS symptoms.
Clinical population described in trial publication.
Neither paper cited here is a trial of BloomEase, and neither is a new trial at all. One is a 2017 literature review in Magnesium Research on magnesium in gynecology, whose authors concluded magnesium may help with period pain and premenstrual symptoms. The other is a 2017 systematic review in Nutrients on magnesium for anxiety and stress, in which four of seven PMS studies reported a benefit and three did not. Both cover ordinary magnesium supplements rather than marine magnesium, the underlying studies used doses and forms that may not match this product, and a review of other people's studies cannot show that this product works.